Remove tag supply
article thumbnail

What you need to know about treating skin tags

The Checkup by Singlecare

Skin tags are one of those things you probably don’t think about until you spot one. At first glance, you may fear it’s a symptom of psoriasis , eczema , HPV warts, or skin cancer —but skin tags are common, noncancerous, and essentially harmless. Read on to see what experts say about the following 13 home remedies for skin tags.

FDA 115
article thumbnail

STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages

STAT

Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, one manufacturer has returned to the market — but is selling its medicine for 10 to 20 times the prices offered by the only other companies with available supplies.

Dosage 106
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. This can reduce the willingness for counterfeit and less accurate data, according to the review. In conclusion, Kordestani et al.

90
article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy supplies, Biogen ditching Aduhelm, and more

STAT

after massive demand and a supply crunch had led it to limit doses last May , STAT writes. The In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. We hope you have a simply smashing day and emerge unscathed.

110
110
article thumbnail

PharmaShots Weekly Snapshots (May 29 - June 02, 2023)

PharmaShots

Impact Therapeutics Entered into a License and Collaboration Agreement with Eikon Therapeutics to Develop and Commercialize IMP1734 Date: June 02, 2023 | Tags: Impact Therapeutics, Eikon Therapeutics, IMP1734, Pharma, China, Hong Kong, Macau, Taiwan BMS’ Mavacamten Receives the NICE Recommendation for the Treatment of Obstructive Hypertrophic (..)

FDA 40
article thumbnail

PharmaShots Weekly Snapshots (May 15 - 19, 2023)

PharmaShots

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

article thumbnail

PharmaShots Weekly Snapshots (June 05 – 09, 2023)

PharmaShots

Quell Therapeutics Signed an Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies Date: June 09, 2023 | Tags: Quell Therapeutics, AstraZeneca, Engineered Treg Cell Therapies, Type 1 Diabetes, Inflammatory Bowel Disease, Biotech, Treg cell engineering modules Astellas and the (..)

FDA 40